Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mogamulizumab efficacy is underscored by its associated rash that mimics cutaneous T-cell lymphoma: a retrospective single-centre case series
Nicholas A. Trum, Jasmine Zain, X. Martínez, et al.
British Journal of Dermatology (2021) Vol. 186, Iss. 1, pp. 153-166
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Clinicopathological definition, management and prognostic value of mogamulizumab‐associated rash and other cutaneous events: A systematic review
Gianluca Avallone, Gabriele Roccuzzo, Alessandro Pileri, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 9, pp. 1738-1748
Open Access | Times Cited: 12
Macrophage-derived CXCL9 and CXCL11, T-cell skin homing, and disease control in mogamulizumab-treated CTCL patients
Adèle de Masson, Delphine Darbord, Gábor Dobos, et al.
Blood (2021) Vol. 139, Iss. 12, pp. 1820-1832
Open Access | Times Cited: 50
Chlormethine gel in combination with other therapies for treatment of mycosis fungoides: a review with patient cases
Marco Ardigò, Neda Nikbakht, Miriam Teoli, et al.
Frontiers in Medicine (2024) Vol. 10
Open Access | Times Cited: 6
Clinical and Real-World Effectiveness of Mogamulizumab: A Narrative Review
M. Fernández‐Guarino, Pablo L. Ortiz‐Romero, Fernando Gallardo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2203-2203
Open Access | Times Cited: 6
Is It Time to Assess T Cell Clonality by Next-Generation Sequencing in Mature T Cell Lymphoid Neoplasms? A Scoping Review
Rina Kansal
Journal of Molecular Pathology (2025) Vol. 6, Iss. 1, pp. 2-2
Open Access
Emergence of bullous pemphigoid under treatment of mycosis fungoides with mogamulizumab
Lukas D. Uleer, Carmen Loquai, Iakov Shimanovich, et al.
JEADV Clinical Practice (2025)
Open Access
Mogamulizumab‐associated rash – Case series and review of the literature
Inga Hansen, Finn Abeck, Anne Menz, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 8, pp. 1079-1086
Open Access | Times Cited: 4
Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab
Francine M. Foss, Youn H. Kim, Julia Scarisbrick, et al.
Journal of Dermatological Treatment (2025) Vol. 36, Iss. 1
Open Access
Praxisempfehlungen für die Therapie und Überwachung von Mogamulizumab‐Patienten in Deutschland
Chalid Assaf, Nina Booken, Edgar Dippel, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2025) Vol. 23, Iss. 3, pp. 341-356
Open Access
Mogamulizumab induces long‐term immune restoration and reshapes tumour heterogeneity in Sézary syndrome*
Marie Roelens, Adèle de Masson, Anaïs Andrillon, et al.
British Journal of Dermatology (2022) Vol. 186, Iss. 6, pp. 1010-1025
Closed Access | Times Cited: 18
Mogamulizumab and Concomitant Hypofractionated Low-Dose Total Skin Electron Beam Therapy (2 × 4 Gy) in Cutaneous T-Cell Lymphoma: Proof of Principle, Report of Two Cases
Mathias Oymanns, Michael Daum-Marzian, Chalid Assaf
Current Oncology (2024) Vol. 31, Iss. 9, pp. 5412-5421
Open Access | Times Cited: 2
Mogamulizumab combined with extracorporeal photopheresis for the treatment of refractory mycosis fungoides and Sézary syndrome. Report of seven cases
Carmen Rubio‐Muñiz, Alba Sánchez‐Velázquez, Jorge Arroyo‐Andrés, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 6
Emerging drugs for the treatment of cutaneous T-cell lymphoma
Melissa Cheng, Jasmine Zain, Steven T. Rosen, et al.
Expert Opinion on Emerging Drugs (2022) Vol. 27, Iss. 1, pp. 45-54
Open Access | Times Cited: 9
Mogamulizumab Multimodality Therapy with Systemic Retinoids, Interferon, or Extracorporeal Photopheresis for Advanced Cutaneous T-Cell Lymphoma
David M. Weiner, Supriya Rastogi, Daniel J. Lewis, et al.
Dermatologic Therapy (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 4
An occurrence of eosinophilic folliculitis and alopecia associated with a sustained complete response to mogamulizumab in Sézary syndrome: a case report
J.-M. L’Orphelin
Therapeutic Advances in Hematology (2024) Vol. 15
Open Access | Times Cited: 1
Safety and effectiveness of mogamulizumab in relapsed or refractory CC chemokine receptor 4‐positive peripheral T‐cell lymphoma and relapsed or refractory cutaneous T‐cell lymphoma: A post‐marketing surveillance in Japan
Kenji Ishitsuka, T Yasukawa, Yukie Tsuji
Hematological Oncology (2024) Vol. 42, Iss. 4
Closed Access | Times Cited: 1
Assessing T‐cell receptor clonality by next‐generation sequencing in atypical cutaneous lymphoid infiltrates and cutaneous T‐cell lymphoma: A scoping review
Michi M. Shinohara, Kerri E. Rieger, Uma Sundram, et al.
Journal of Cutaneous Pathology (2024) Vol. 51, Iss. 10, pp. 813-819
Closed Access | Times Cited: 1
Mogamulizumab‐induced granulomatous dermatitis of the scalp: a distinct entity associated with clinical response
A. Pacaud, E. Criquet, A. Durlach, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 10
Closed Access | Times Cited: 7
Mogamulizumab‐associated rashes, their presentation and prognostic significance: a single‐centre retrospective case series analysis
Alessandro Pileri, Giacomo Clarizio, Corrado Zengarini, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 37, Iss. 5
Closed Access | Times Cited: 7
Head and neck granulomatous rash associated with mogamulizumab mimicking mycosis fungoides
Jingying Wang, C. Ram‐Wolff, Gábor Dobos, et al.
British Journal of Dermatology (2022) Vol. 187, Iss. 1, pp. 129-131
Closed Access | Times Cited: 6
Mogamulizumab‐associated rash: A challenging case report and literature review
Sandra Martínez‐Fernández, Haejin Oh, Carmen Couselo‐Rodríguez, et al.
Australasian Journal of Dermatology (2023) Vol. 64, Iss. 2
Closed Access | Times Cited: 2
Histopathological Markers for Target Therapies in Primary Cutaneous Lymphomas
Benedetta Sonego, Adalberto Ibatici, Giulia Rivoli, et al.
Cells (2023) Vol. 12, Iss. 22, pp. 2656-2656
Open Access | Times Cited: 2
Mogamulizumab‐assoziierter Rash – Fallserie und aktuelle Literatur
Inga Hansen, Finn Abeck, Anne Menz, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 8, pp. 1079-1087
Closed Access
Mogamulizumab-associated rash: Kutanes T-Zell-Lymphom in vollständiger Remission
Anna Leonhardt, Michaela Maurer, Michael J. Flaig
Deleted Journal (2024) Vol. 75, Iss. S1, pp. 5-8
Closed Access
Practical recommendations for therapy and monitoring of mogamulizumab patients in Germany
Chalid Assaf, Nina Booken, Edgar Dippel, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024)
Open Access
Page 1 - Next Page

Scroll to top